logo-loader
viewRoyal Dutch Shell

Royal Dutch Shell and Blackstone reportedly working on joint US$10bn bid for BHP Billiton’s US shale assets

Shell and Blackstone's offer will only be one of several credible proposals that the world’s biggest miner will receive for the operations, Sky News said on Thursday, citing banking sources

Shale drilling
BHP Billiton put the shale business up for sale last year and said last month that initial bids are expected in the June quarter

Royal Dutch Shell PLC (LON:RDSA) and US private equity firm Blackstone Group LP (NYSE:BX) are reportedly working on a joint US$10bn bid for BHP Billiton PLC’s (LON:BLT) US shale assets.

Shell and Blackstone's offer will only be one of several credible proposals that the world’s biggest miner will receive for the operations, Sky News said on Thursday, citing banking sources.

READ: BHP Billiton posts 25% jump in underlying half-year profit, as metal prices rise, but misses consensus

The FTSE 100-listed firm’s acreage is located adjacent to assets controlled by Shell and Russia’s Anadarko Petroleum Corp in the Permian Basin of west Texas and New Mexico.

BHP Billiton put the shale business – which is on its books at US$14bn -- up for sale last year and said with results last month, that initial bids are expected in the June quarter.

The disposal move was one of the strategic changes urged last year by US activist investor Elliott Management which has a 5% holding in BHP Billiton.

Earlier this week, Devon Energy sold some of its shale-gas assets in Texas for US$553mln to what energy analysts identified as a private equity firm, although Devon did not disclose the name of the buyer.

In London, BHP Billiton shares were 0.7% higher at 1,413.8p, while Shell A shares were down 0.8% at 2,247.5p, and in pre-market New York trading, Blackstone shares edged up 0.1% to US$33.45.

 -- Adds share prices --

Quick facts: Royal Dutch Shell

Price: 31.64 USD

NYSE:RDS.A
Market: NYSE
Market Cap: $123.9 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: CytoDyn's therapy used to treat New York coronavirus...

CytoDyn Inc (OTCMKTS:CYDY) CEO Nader Pourhassan tells Proactive the biotech shared positive test results today from seven coronavirus (COVID-19) patients who were treated with the company’s drug leronlimab at a leading medical center in the New York City area. Pourhassan, together diagnostics...

1 day, 1 hour ago

2 min read